Literature DB >> 34260066

SARS-CoV-2 re-infection in a cancer patient with a defective neutralizing humoral response.

Cinzia Borgogna1, Marco De Andrea2,3, Gloria Griffante1, Alessia Lai4, Annalisa Bergna4, Massimo Galli4, Gianguglielmo Zehender4, Luigi Castello5, Paolo Ravanini6, Carlo Cattrini7, Alessia Mennitto7, Alessandra Gennari7, Marisa Gariglio1.   

Abstract

Entities:  

Keywords:  Cancer patient; Neutralization humoral response; Re-infection; SARS-CoV-2

Year:  2021        PMID： 34260066     DOI： 10.1002/jmv.27200

Source DB:  PubMed          Journal:  J Med Virol        ISSN： 0146-6615            Impact factor:   2.327


× No keyword cloud information.
  4 in total

1.  Persistence of Neutralizing Antibodies to SARS-CoV-2 in First Wave Infected Individuals at Ten Months Post-Infection: The UnIRSA Cohort Study.

Authors:  Gloria Griffante; Shikha Chandel; Daniela Ferrante; Valeria Caneparo; Daniela Capello; Valentina Bettio; Cinzia Borgogna; Chiara Aleni; Salvatore Esposito; Andrea Sarro; Alessandra Vasile; Marco Comba; Tommaso Testa; Gianmarco Cotrupi; Marco De Andrea; Sara Bortoluzzi; Marisa Gariglio
Journal:  Viruses       Date:  2021-11-12       Impact factor: 5.048

Review 2.  Reinfection in patients with COVID-19: a systematic review.

Authors:  Xiangying Ren; Jie Zhou; Jing Guo; Chunmei Hao; Mengxue Zheng; Rong Zhang; Qiao Huang; Xiaomei Yao; Ruiling Li; Yinghui Jin
Journal:  Glob Health Res Policy       Date:  2022-04-29

3.  Effects of Antibody Responses to Pre-Existing Coronaviruses on Disease Severity and Complement Activation in COVID-19 Patients.

Authors:  Massimo Cugno; Pier Luigi Meroni; Dario Consonni; Samantha Griffini; Elena Grovetti; Cristina Novembrino; Adriana Torri; Gloria Griffante; Marisa Gariglio; Luca Varani; Flora Peyvandi
Journal:  Microorganisms       Date:  2022-06-10

4.  Patterns of neutralizing humoral response to SARS-CoV-2 infection among hematologic malignancy patients reveal a robust immune response in anti-cancer therapy-naive patients.

Authors:  Cinzia Borgogna; Riccardo Bruna; Gloria Griffante; Licia Martuscelli; Marco De Andrea; Daniela Ferrante; Andrea Patriarca; Abdurraouf Mokhtar Mahmoud; Valentina Gaidano; Monia Marchetti; Davide Rapezzi; Michele Lai; Mauro Pistello; Marco Ladetto; Massimo Massaia; Gianluca Gaidano; Marisa Gariglio
Journal:  Blood Cancer J       Date:  2022-01-18       Impact factor: 11.037
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.